You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: July 27, 2024

CLINICAL TRIALS PROFILE FOR SETANAXIB


✉ Email this page to a colleague

« Back to Dashboard


Clinical Trials for Setanaxib

Trial ID Title Status Sponsor Phase Summary
NCT04327089 ↗ Study to Evaluate the Pharmacokinetics and Drug-Drug Interactions of Setanaxib in Healthy Adult Male and Female Subjects Completed Genkyotex SA Phase 1 The study is a monocentric, open label, phase 1 study to evaluate the pharmacokinetics, and in particular the dose proportionality of setanaxib and its metabolites after a single oral dose (400 mg, 800 mg, 1200 mg, and 1600 mg) (Part 1) and after multiple oral doses (Part 2).
NCT05014672 ↗ A Trial of Setanaxib in Patients With Primary Biliary Cholangitis (PBC) and Liver Stiffness Not yet recruiting Genkyotex Suisse SA Phase 2/Phase 3 The primary objective of this study is to evaluate the effect of setanaxib on biochemical response at Week 52 in participants with primary biliary cholangitis (PBC) and with elevated liver stiffness and intolerance or inadequate response to ursodeoxycholic acid (UDCA).
NCT05323656 ↗ A Phase 2, Randomised Study of Setanaxib Co-Administered With Pembrolizumab in Patients With Recurrent or Metastatic SCCHN Recruiting Genkyotex Suisse SA Phase 2 The primary objective of this study is to compare the change in tumour size per Response Evaluation Criteria in Solid Tumours Version 1.1 (RECIST v1.1) in recurrent or metastatic SCCHN patients treated with setanaxib and pembrolizumab versus patients treated with placebo and pembrolizumab.
>Trial ID >Title >Status >Phase >Summary

Clinical Trial Conditions for Setanaxib

Condition Name

Condition Name
Intervention Trials
Liver Stiffness 1
Phase 1 1
Primary Biliary Cholangitis 1
Squamous Cell Carcinoma of Head and Neck 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Condition MeSH

Condition MeSH
Intervention Trials
Squamous Cell Carcinoma of Head and Neck 1
Carcinoma, Squamous Cell 1
Carcinoma 1
Liver Cirrhosis, Biliary 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Locations for Setanaxib

Trials by Country

Trials by Country
Location Trials
France 1
Spain 1
United States 1
This preview shows a limited data set
Subscribe for full access, or try a Trial

Trials by US State

Trials by US State
Location Trials
Mississippi 1
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Progress for Setanaxib

Clinical Trial Phase

Clinical Trial Phase
Clinical Trial Phase Trials
Phase 2/Phase 3 1
Phase 2 1
Phase 1 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Status

Clinical Trial Status
Clinical Trial Phase Trials
Completed 1
Not yet recruiting 1
Recruiting 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Sponsors for Setanaxib

Sponsor Name

Sponsor Name
Sponsor Trials
Genkyotex Suisse SA 2
Genkyotex SA 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Sponsor Type

Sponsor Type
Sponsor Trials
Industry 3
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.